1. Home
  2. LINK vs MREO Comparison

LINK vs MREO Comparison

Compare LINK & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Interlink Electronics Inc.

LINK

Interlink Electronics Inc.

HOLD

Current Price

$5.48

Market Cap

59.5M

Sector

Technology

ML Signal

HOLD

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$0.34

Market Cap

52.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LINK
MREO
Founded
1984
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.5M
52.5M
IPO Year
2007
2017

Fundamental Metrics

Financial Performance
Metric
LINK
MREO
Price
$5.48
$0.34
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$8.67
$1.50
AVG Volume (30 Days)
79.7K
1.8M
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
45.83
16.67
EPS
N/A
N/A
Revenue
$11,890,000.00
$500,000.00
Revenue This Year
$43.26
$5,184.20
Revenue Next Year
$19.16
$55.51
P/E Ratio
N/A
N/A
Revenue Growth
1.81
N/A
52 Week Low
$2.66
$0.20
52 Week High
$15.15
$2.94

Technical Indicators

Market Signals
Indicator
LINK
MREO
Relative Strength Index (RSI) 79.57 67.99
Support Level $3.40 $0.31
Resistance Level $10.55 $0.36
Average True Range (ATR) 0.54 0.04
MACD 0.19 0.01
Stochastic Oscillator 81.69 98.05

Price Performance

Historical Comparison
LINK
MREO

About LINK Interlink Electronics Inc.

Interlink Electronics Inc is a sensor and printed electronics company operating in two principal sensor technology divisions: force/touch sensors, and gas and environmental sensors. It designs, develops, manufactures and sells a range of force-sensing and gas-sensing technologies that incorporate its proprietary materials technology, firmware and software into a portfolio of standard sensor-based products and custom sensor system solutions. Its force-sensing products and solutions include sensor components, subassemblies, modules products that support effective, efficient cursor control and novel three-dimensional user inputs. Its Human Machine Interface technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: